Non issuethis was known in worsening HF symptoms, it was discussed ad naseum previously here, the treatment works and is better than any SOC currently available in reducing MACE events, MI/stroke extending patient and quality of life.
Glad to see it peer reviewed and accepted
Ann: DREAM HF Trial Published in JACC, page-40
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.09 | $4.804M | 4.325M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 106389 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 118800 | 15 |
View Market Depth
| Last trade - 14.00pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |